Vertex Pharmaceuticals Shares Surge 9% After Kidney Drug Success
The company reported positive late-stage trial results for its experimental kidney treatment, boosting investor confidence and driving stock gains.
Summary
No Summary provided as the original text is short
Terms & Concepts
Late-stage study: A Phase 3 clinical trial conducted to confirm a drug's efficacy and safety before regulatory approval.
Vertex Pharmaceuticals (VRTX): A U.S. biotechnology company known for developing treatments for serious diseases, including cystic fibrosis and kidney disorders.